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ABSTRACT 
 
Nicotine and its derivatives, by binding to nicotinic acetylcholine receptors (nAChRs) on 
bronchial epithelial cells, can regulate cellular signaling and inflammatory processes. 
Delineation of nAChR subtypes and their responses to nicotine stimulation in bronchial 
epithelium may provide information for therapeutic targeting in smoking-related 
inflammation in the airway.  
Expression of nAChR subunit genes in 60 bronchial epithelial biopsies and 
immunohistochemical staining for the subcellular locations of nAChR subunit expression 
were evaluated. Seven human bronchial epithelial cell lines (HBECs) were exposed to 
nicotine in vitro for their response in nAChR subunit gene expression to nicotine 
exposure and removal.  
The relative normalized amount of expression of nAChR α4, α5 and α7 and 
immunohistochemical staining intensity of nAChR α4, α5 and β3 expression showed 
significant correlation with lung function parameters. Nicotine stimulation in HBECs 
resulted in transient increase in the levels of nAChR α5 and α6 but more sustained 
increase in nAChR α7 expression.  
nAChR expression in bronchial epithelium was found to correlate with lung function. 
Nicotine exposure in HBECs resulted in both short and longer term responses in nAChR 
subunit gene expression. These results gave insight into the potential of targeting nAChRs 
for therapy in smoking-related inflammation in the airway. 
(Abstract word count: 197) 
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INTRODUCTION 
   
Tobacco smoking is an important cause of lung function impairment, more commonly 
manifest as airflow obstruction on lung function tests. Nicotine in tobacco smoke is also 
one major component to cause damage to bronchial epithelium as well as being a 
potential carcinogen for the lung (12, 16). There were previous reports of nicotine 
stimulation of normal bronchial epithelium giving rise to aberrant Akt or NF-kB signaling 
that may contribute to the development of airway inflammation. Recent discoveries of 
functional acetylcholine receptors on lung epithelial cells and lung tumors raise the 
question of whether exposure to nicotine could participate in pathogenesis of airway 
disorders, one example would be chronic obstructive pulmonary disease (COPD). COPD 
is defined as an airway disorder resulting from chronic exposure to noxious gaseous 
substance like tobacco smoke and it usually manifests with respiratory symptoms 
together with the detection of non-reversible airflow obstruction on lung function tests (1). 
The ratio of forced expiratory volume in one second (FEV1) to forced vital capacity 
(FVC), i.e. FEV1/FVC ratio of less than 70% is an indicator of airflow obstruction (1). 
Studying the pattern of nicotinic acetylcholine receptor (nAChR) expression in bronchial 
epithelium might provide information that nicotine is playing a role via specific subtypes 
of nAChRs in development of airflow obstruction. 
nAChRs are found in non-neuronal tissues, such as α3, α5 and α7 in cultured 
bronchial epithelial cells (10, 22) but the pattern of nAChR expression is not completely 
delineated in human bronchial epithelial tissue. The mechanisms and contributions 
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towards development of lung disease by these various nAChR subunits are not well 
defined. 
Recent meta-analysis has implicated the CHRNA3-CHRNB4-CHRNA5 region on 
chromosome 15q25 to be associated with nicotine dependence, and this region is known 
to encode the different nAChR α subunits (21) (CHRN being the gene symbol for nAChR). 
In one study, genetic variants in this 15q24/25 region are associated with emphysema (8, 
13), while large scale genome wide association study suggested that variants in that 
region could be genetic risk factor for the development of airflow obstruction 
independent of smoking (20). There is also evidence from Genome-Wide Association 
Study (GWAS) that these nAChR clusters may act on COPD development via 
susceptibility to smoking but not directly on development of COPD (2). 
 In this study, we aimed to delineate the expression pattern of nAChR subunits in 
bronchial epithelium, from normal looking areas at bronchoscopy with autofluorescence 
imaging (AFI), in correlation with clinical characteristics and lung function. 
Immortalized normal bronchial epithelial cell lines were established from the bronchial 
epithelial biopsy and were tested for nAChR expression in response to nicotine exposure 
for nine days. The results from these experiments would provide insight into the 
following scientific questions: What are the cellular locations for different nAChR 
subunit expression and what could be the anatomical and functional implications? Can 
these immortalized bronchial epithelial cell lines be models for further study of the 
functional role of nAChR in bronchial epithelium? Understanding the pattern and 
regulatory mechanisms of nAChR subunit expression in human airway may give insight 
into their roles in inflammatory airway disorders and relevant lung function changes. 
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MATERIALS AND METHODS 
 
This was a prospective cohort study. Consecutive subjects, who have sputum atypia 
undergoing bronchoscopy with autofluorescence imaging (AFI) (Figure 1), were 
recruited. The inclusion criteria were sputum cytology examination demonstrating 
atypical cells but recent chest imaging did not reveal localizing lesion accountable for the 
sputum detection of atypical cells; and able to give informed written consent. The 
exclusion criteria were patients having active hemoptysis; or patients with bleeding 
tendency or on oral anticoagulation which may increase the risk of bleeding from 
bronchoscopic biopsies even if oral anticoagulation was stopped before bronchoscopy. 
Chest radiographs (CXRs) and computed tomography (CT) thorax scans were done in the 
six weeks before they were referred for AFI. Spirometry was performed three days before 
bronchoscopy. The study was approved by HKU/HKHA HKWC EC/IRB local 
Institutional Review Board (IRB) of the University of Hong Kong (HKU)/Hong Kong 
Hospital Authority Hong Kong West Cluster (HK HA HKWC 09-120) and the research 
has been carried out in accordance with the Declaration of Helsinki (2008). Non-smokers 
were patients who have never smoked for their life-time. Smokers included current 
smokers who have been current active chronic smokers and ex-smokers who have been 
daily smoking for more than twelve months in the past but have quit smoking for at least 
twelve months before bronchoscopy. Chronic smokers were asked to stop smoking, in 
particular on the day before lung function tests and bronchoscopy. 
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At bronchoscopy with AFI, suspicious areas will show up as areas of magenta 
fluorescence color, in contrast to the green fluorescence color for normal bronchial 
epithelium (Figure 1). After diagnostic specimens were biopsied from magenta areas, 
four additional bronchial biopsies would be taken from the adjacent green fluorescent 
areas for this study. The first piece of these four additional biopsies was cultured, while 
the next two pieces were paraffinized for histological sectioning, and the final one piece 
was saved in RNAlater solution (Qiagen, Hilden, Germany). Total RNA was extracted 
from the piece of bronchial biopsy kept in RNAlater solution. Lung function tests were 
performed with the Vmax Encore lung function test system (CareFusion, San Diego, CA, 
USA) and test results were interpreted according to the American Thoracic Society – 
European Respiratory Society recommendations (11). 
 
Immortalized bronchial epithelial cell lines 
 
Four immortalized bronchial epithelial cell lines, HBEC-KT 2 – 5, were used (from John 
Minna MD, University of Texas Southwestern Medical Center at Dallas, USA) (15). 
Three cell lines were established from recruited subjects with immortalization using the 
same laboratory protocol (15) and they were all beyond 100 passages at the time of these 
experiments. These new cell lines were named HKBS62N-KT, HKBS65.2N-KT and 
HKBS150N-KT. 
 
Complementary DNA synthesis 
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Total RNA was extracted from tissue specimens and cell lines. RNA samples (1 μg) were 
reverse transcribed in 20 μl reaction mix (5x First-Strand Buffer [ThermoFisher 
Scientific, Waltham, MA, USA], DTT [100 mM, Promega, Madison, WI, USA], dNTP 
[1mM, Amersham Biosciences, Bath, UK], oligo-dT12-18 primers [ThermoFisher 
Scientific, Waltham, MA, USA] and random hexamer [Promega, Madison, WI, USA], 
RNaseOUT Recombinant Ribonuclease Inhibitor [ThermoFisher Scientific, Waltham, 
MA, USA] and Superscript II Reverse Transcriptase [ThermoFisher Scientific, Waltham, 
MA, USA]) with one-hour reaction at 42oC. 
 
Quantitative PCR reactions 
 
The primers spanning across intron-exon junctions were designed for quantitative PCR 
targeting nAChR subunit genes α3, α4, α5, α6, α7, β2, β3and β4 with 18S as the reference 
gene. The methodology used was the same as described before (7).  Quantitative PCR 
reactions were carried out in triplicates. SYBR Green I (SYBR Green JumpStart Taq 
ReadyMix [Sigma-Aldrich, Saint Louis, MO, UA]) was used as the detection dye and 
ribosomal 18S was used as the reference gene. Final reaction volume was 10 μl with 1.25 
μl of 1/10 TE-diluted cDNA from RT reaction, 0.1 μM of each specific primer, 5 μl 
SYBR Green Jumpstart Taq ReadyMix. Quantitative PCR cycles were set at 10 min 
denaturation, followed by 40 cycles of 95oC for 15s, 60oC for 5s and 72oC for 20s; and 
72oC for 10min as the final extension step. Dissociation curves were inspected for each 
pair of primers and only one dissociation peak must be present for each run of reaction 
before the results were considered to be valid. A five-fold serial dilution of a reference 
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sample was used for construction of standard curves with respect to each pair of primers. 
Quantitative PCR was run for each tumor or cell line cDNA sample and the Ct for a 
particular sample was obtained from the standard curves for a specific pair of primers. 
The Ct for unknown samples was compared with Ct of reference samples to obtain the 
Normalized Relative Amount for unknown samples. The Normalized Relative Amount 
was then log2 transformed and approximation to normal distribution estimated. For qPCR 
data, the Normalized Relative Amount for all samples was multiplied by a common 
factor of 1024 and then Log2 transformed used for transformed qPCR data for direct 
visual inspection and comparison (7). The relative normalized amount of each nAChR 
subunit gene expression was correlated with lung function parameters. 
 
Immunohistochemistry 
  
nAChR antibodies (Santa Cruz, Dallas, Tx, USA) targeting different subunits α3, α4, α5, 
α6, α7, β2 and β3 were used for tissue sections of bronchial epithelium. The 
immunohistochemical staining intensity (Grade 0 – 3) of nAChR at different cellular 
locations (bronchial cell cytosol, bronchial gland serous membrane, bronchial gland 
mucus component) was scored by an independent pathologist (K-H Fu) who was blinded 
to the clinical information of all recruited subjects (Figure 2). The scored grading of each 
bronchial biopsy was correlated with lung function parameters. 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
Response to nicotine exposure in normal human bronchial epithelial cell lines 
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Seven NHBE cell lines, i.e. HBEC-KT 2 - 5 (15) and HKBS62N-KT, HKBS65N-KT and 
HKBS150N-KT, were cultured and equal number of passages for each cell lines were 
randomized into nicotine group and control group. The HBECs were seeded and 
incubated for 24 hours before addition of nicotine. On day 0, nicotine (100nM) was 
added to the nicotine group and the same volume of culture medium without nicotine was 
added to the control group. Nicotine at 100nM was found to be an easily achievable 
serum level in smokers (9). Both groups were further incubated for 9 days when the 
nicotine will be removed, with interim change of medium for once with nicotine medium 
replacement and plain medium without nicotine for each group. On day 9, both groups 
will switch to plain medium and were allowed to grow until day 12. Cells were harvested 
on days 0, 3, 6, 9, 12 days. Nine days were chosen as the usual population doubling time 
was around ten days for these cultured bronchial epithelial cells. Total RNA was 
extracted for reverse transcription and quantitative PCR as described above. 
 
Statistical analysis 
 
Student t tests, with assumptions of two-tails and unequal variance, were used for 
comparison of expression level of different subunit genes between groups of samples 
with different gender and smoking history. All expression levels were logarithmic 
transformed to achieve data normality. Chi-square tests were used for comparing the 
distribution of smokers and non-smokers with high or low mean expression of individual 
or combinations of nAChR subunit genes. Bonferroni adjustments were applied when 
multiple comparisons of the expression levels or immunohistochemical staining results 
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across different nAChR subunits. Statistical tests were carried out with IBM PASW for 
Windows version 21 (IBM, Armonk, New York, USA). 
 
RESULTS 
 
Demographics of recruited subjects 
 
Seventy consecutive patients were referred for bronchoscopy with AFI for sputum atypia 
(Figure 1). Six declined participation in the study. Four subjects were not recruited 
because of recent treatment with oral anticoagulation. Sixty subjects were recruited with 
informed written consent obtained. There were 52 men and 8 women. The mean age was 
61.8 ± 10.8 years. 32 of them were chronic smokers (53.3%), 19 were ex-smokers (31.7%) 
and 9 were non-smokers (15%). The mean amount of smoking was 24.9 ± 20.3 pack-
years. The bronchial biopsies were reviewed by an independent pathologist (KHFu) who 
was not involved in subject recruitment and were blinded to their clinical characteristics. 
Out of the sixty bronchial biopsy specimens, 56 (93.3%) showed normal bronchial 
epithelium while two biopsies from smokers showed squamous metaplasia and two other 
biopsies from smokers showed moderate squamous dysplasia. The demographic 
characteristics of these lung cancer patients were summarized in Table 1. These recruited 
subjects were not diagnosed to have COPD before and they have no significant 
respiratory symptoms. Airflow obstruction (defined as FEV1/FVC < 70% on lung 
function tests)(1) was found in 37 (61.7%) of subjects with FEV1/FVC of 65.8 ± 12.9% 
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most of which were considered mild degree of airflow obstruction with FEV1 (% of 
predicted) at 87 ± 17.9%. CT scan of thorax for all the subjects showed no abnormalities. 
 
Quantitative PCR analysis of nAChR subunit gene expression 
 
The relative normalized amount of nAChR mRNA expression of nAChR α4, α5 and α7 
showed significant correlation with lung function, adjusted for gender and smoking 
(Table 2). The mRNA expression level of nAChR α4 was found to correlate with most 
spirometry parameters of FEV1 (r = 0.325, p = 0.023) (Figure 3A), FEV1 (% pred) (r = 
0.375, p = 0.010), FVC (r = 0.485, p = 0.041), FVC (% pred) (r = 0.593, p = 0.022). The 
same correlation patterns were found for nAChR α5 mRNA expression level, correlating 
with FEV1 (r = 0.338, p = 0.049)(Figure 3B), FEV1 (% pred) (r = 0.403, p = 0.026), FVC 
(r = 0.469, p = 0.024), FVC (% pred) (r = 0.587, p = 0.011), and for nAChR α7 mRNA 
correlating with  FEV1 (r = 0.370, p = 0.034)(Figure 3C), FEV1 (% pred) (r = 0.425, p = 
0.011), FVC (% pred) (r = 0.576, p = 0.048). The nAChR β2 mRNA was found to 
correlate with FEV1/FVC ratio (r = -0.219, p = 0.011). 
 
Immunohistochemical staining 
  
Out of sixty subjects recruited, 39 endobronchial biopsies were found to be of sufficient 
evaluable quality after histological examination to proceed on to immunohistochemistry. 
The age and gender distribution, smoking status and lung function parameters of these 39 
subjects were found to be similar and not significantly different from those characteristics 
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of the whole group of 60 recruited subjects (Table 1). The staining intensity of nAChR α4 
bc (surface epithelial cytosol staining), α5 sc (bronchial gland serous cell cytosol staining) 
and β3 mc (bronchial gland mucous cell staining) intensity (Figure 2) was found to 
correlate with lung function parameters. The nAChR α4 bc staining intensity was found to 
correlate with FVC (% pred) (r = 0.552, p = 0.025), while nAChR α5 sc staining intensity 
was found to correlate with FEV1 (% pred) (r = 0.369, p = 0.026) and nAChR β3 mc 
staining intensity correlated with FEV1 (r = 0.367, p = 0.035), adjusted for the effects of 
age, gender and smoking status of included subjects (Table 3). 
 
Correlations of nAChR subunit gene mRNA expression levels with 
immunohistochemical staining intensity 
  
The mRNA expression levels of nAChR subunit gene α4, α5, α7 and β2 showed 
significant and highest correlation coefficient with the corresponding 
immunohistochemical staining intensity (Table 4). There were also significant but weaker 
correlations between the mRNA expression levels with immunohistochemical staining 
intensity for nAChR α4, α5, α6 and α7 (Table 4), and the significance remains after 
adjustment for multiple comparisons. 
 
Exposure of normal human bronchial epithelial cell lines to nicotine 
 
When HBEC lines were exposed to 100 nM nicotine and then RNA harvested at days 0, 3, 
6, 9 and 12, a significant rise in the expression levels of CHRN A5 and A7 were found 
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with rapid return to baseline levels of expression upon nicotine removal (Figures 4 A and 
4C). There was a sharp rise in nAChR α5 subunit gene expression upon exposure to 
nicotine, and a similar sharp but slightly delayed rise in nAChR α7 subunit gene 
expression. Both these responses dropped with withdrawal of nicotine on day nine 
(Figures 4A and 4C). There was also a sharp but not sustained rise in nAChR α6 subunit 
upon nicotine exposure and it dropped after day 6 before nicotine was removed on day 9 
(Figure 4B). No significant rise or fall was found in the levels of expression of other 
nAChR subunit genes including CHRN A3, A4, B2, B3 and B4 analysed.                                                                                                                                             
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DISCUSSION 
 
The distribution, function and ligand-binding affinity of nAChR depends on the composition of 
nAChR subunits, although the exact function and physiological roles of individual nAChR 
subtypes are not completely understood. To our knowledge, the correlation of expression of 
these nAChR subunits with lung function has not been reported before. The quantitative PCR 
analysis of nAChR subunit gene expression levels allowed for quantitative comparison between 
groups of samples with respect to gender and smoking habits. 
 In this study the most significant correlations between lung function parameters and 
nAChR α4, α5 and α7 expression levels or the corresponding immunohistochemical staining 
intensity of each nAChR subunit expression. CHRNA5 is known to be associated with nicotine 
dependence (21) and the presence of emphysema in smokers (8, 13). The result of this study 
provided direct support to previous GWAS study that CHRNA5 expression was linked to the 
development of airflow obstruction (20) independent of effects of age, gender and smoking 
status. The subjects included in this subjects were either having no airflow obstruction or just 
mild degree of it (FEV1 [% of predicted value] between 50 – 80%). The presence of nAChR α5 
subunit in nAChR has been shown to alter the calcium permeability and nicotine sensitivity in 
vitro (5). nAChR α7 subunit was found to be important in the control of nicotine-induced 
calcium-influx in SCLC (17) and was thus thought to be important in growth signal transduction 
induced by nicotine binding to nAChR. The expression of nAChR α5 and α7 in normal bronchial 
epithelium suggested that they may play similar roles in nAChR signaling and such correlation 
with airflow parameters on lung function tests would suggest that there could be activated 
nAChR signaling in response to nicotine in smokers correlating with airflow obstruction. 
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Although we have found significant reduction in nAChR α4 expression in lung cancer (7), 
there is so far no further evaluation of its role in normal bronchial epithelium. There is recent 
evidence that nAChR α7 and α4β2 activation (16) could be associated with transactivation via 
cyclic adenosine monophosphate (cAMP) stimulation of the epidermal growth factor receptor 
(EGFR) signaling pathways inducing cell growth and proliferation, thus may contribute to 
carcinogenesis (16). This cAMP activation could also be potential target for phosphodiesterase 
inhibition, which is one therapeutic strategy in targeting inflammation in COPD (1). The 
transient but not sustainable nAChR α6 that dropped before nicotine withdrawal was also 
intriguing and deserves further investigation into the roles of nAChR α6 in normal bronchial 
epithelial cells. 
CHRNA5 and A7 showed significant reversible induction of expression on in vitro 
exposure to nicotine, providing direct evidence that these subunit genes respond to acute nicotine 
exposure and could mediate the immediate or short term effects of nicotine. Little is known 
about the functional significance of the expression these specific CHRNA5 and A7 in the central 
nervous system or in lung cancer, though CHRNA7 had been reported to be expressed in SCLC 
cell lines (18) and was thought to be related to smoking in schizophrenic patients (4). Up-
regulation of functional CHRNA7 has also been demonstrated in normal human bronchial 
epithelial cells on exposure to nicotine (19). The return of the expression levels of those three 
subunits, of nAChR α5, α6 and α7, to baseline upon cessation of nicotine exposure may reflect 
that continued or chronic exposure to nicotine (usually taken to be more than 10 days) of 
continuous exposure to nicotine (14) was required for nicotine addiction or other cellular effects 
of nicotine mediated by specific nAChR subunits. The effects of chronic exposure to nicotine on 
nAChR subunit gene expression in these normal human bronchial epithelial cells and whether the 
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same response is maintained, or other nAChR subunit genes would be involved, in chronic 
nicotine exposure warrant further evaluation. 
In neural tissues, the up-regulation of nAChRs in response to chronic nicotine is 
consistently reported as post-translational events without changes in mRNA (3, 6). In this study, 
we have demonstrated nicotine induced increases in the expression levels of both nAChR mRNA 
and protein in culture bronchial epithelial cells, nicotine-induced up-regulation of nicotinic 
receptors in bronchial epithelial cells may include both transcriptional and post-translational 
mechanisms. 
 Although this is a small sample size, it did show correlation between different nAChR 
subunits in terms of mRNA expression level and the protein expression level by 
immunohistochemical staining. nAChR expression was correlated with lung function parameters 
that are suggestive of airflow obstruction. The other parts of lung function tests including lung 
capacity assessment and diffusion capacity measurements were not performed in this study. This 
supported our initial hypothesis of correlations between nAChR expression and lung functions, 
contributing to the development of airflow obstruction which could be one characteristic of 
smokers with COPD. Validation in a larger cohort of smoker and non-smoker subjects would be 
warranted but this initial sample of 60 apparently healthy subjects were already difficult to 
recruit. The chance of validation in COPD subjects would be even more difficult as there is 
seldom indication for bronchoscopic biopsy or surgical biopsy in COPD subjects, adding to the 
difficulties in performing similar clinical studies. The functional roles of different nAChR 
subunits, working on individual basis or in combination, in bronchial epithelium and how their 
expression levels translate into lung function abnormalities and ultimately clinical airflow 
obstruction requires further work. 
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 In summary, there are correlations between nAChR subunit expression in the bronchial 
epithelium with lung function parameters. These nAChR subunit genes could be contributing to 
the development of airflow obstruction in smokers. Further evaluation of the functions and roles 
played by these nAChR subunit genes in the development of tobacco-related airway disorders are 
warranted. 
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Legends for Figures and Tables 
 
Table 1 
Basic demographics of all the 60 recruited subjects and the corresponding demographics 
of 39 subjects with biopsies evaluable by immunohistochemistry (IHC evaluable) are also 
listed in parallel 
 
Table 2 
Partial correlations of relative normalized amount of each CHRN subunit gene mRNA 
expression levels with lung function parameters 
 
Table 3 
Correlations of expression level of different nAChR by immunohistochemical intensity 
with lung function parameters.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
 
Table 4 
Correlation matrix of nAChR mRNA expression levels with immunohistochemical 
intensity. 
 
Figure 1 
Side by side comparison of endoscopic view with (a) and (b) showing ordinary white-
light bronchoscopy (WLB) and the corresponding view under autofluorescence imaging 
(AFI), with the green fluorescence in AFI representing normal bronchial epithelium while 
the magenta areas (arrows) indicating the potential sites of abnormalities not visualized 
on the corresponding WLB views. Bronchial biopsies for this study were taken away 
from AFI magenta areas where the areas appeared green in fluorescence under AFI. 
 
Figure 2 
(A) Immunostaining pattern of bronchial epithelial cells. Apical cell membrane (bm), 
arrow heads and cytosol (bc), long arrows. There is accentuation of the staining at 
the apical cell membrane and terminal web (arrows) of the ciliated bronchial cells 
compared with the cytosol. Immunostain for nAChRs α4, Nikon Eclipse Ni-U 
with Plan Achromat 40x objective, c-mount 0.7x and 2/3” CCD camera with 5 
mega pixels. 
(B) Immunostaining pattern of bronchial gland acini. Serous cells (sc), arrowheads 
and mucous cells (mc), long arrows. The staining reaction is seen mainly within 
the cytosol. Immunostain for nAChRs α3, Nikon Eclipse Ni-U with Plan 
Achromat 20x objective, c-mount 0.7x and 2/3” CCD camera with 5 mega pixels.  
 
Figure 3 (A – C) 
Scatter plots showing significant correlations of FEV1 with relative normalized 
amount of (A) CHRNA4; (B) CHRNA5 and (C) CHRNA7 mRNA expression level. 
 
Figure 4 (A – C) 
Graphic representations of the results of nicotine exposure for nine days in immortalized 
bronchial epithelial cells (with the red series summarizing the mean +/- SE of  cell lines 
exposed to nicotine [treatment group] and with the blue series representing the respective 
 23 
cell lines without exposure to nicotine[control group]) showing (A) sharp rise in nAChR 
α5 subunit gene expression upon exposure to nicotine, with a similar sharp but (C) a 
slightly delayed rise in nAChR α7 subunit gene expression. Both these responses dropped 
with withdrawal of nicotine on day nine. (B) There was also a sharp but not sustained rise 
in nAChR α6 subunit upon nicotine exposure but it dropped after day 6 before nicotine 
was removed on day 9. 
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Table 1 
       
N 60 (Total) 39 (IHC evaluable) 
Gender (F:M) 8:52 4:35 
F 8 (13.3%) 4 (10.3%) 
M 52 (86.7%) 35 (89.7%) 
Mean Age (years +/- SD) 61.8 ± 10.8 63.1 ± 9.9 
Range 30-83 33 – 79 
Smoking status (NS:CS:EX)   NS 9 (15.0%) 6 (15.3%) 
CS 32 (53.3%) 19 (48.7%) 
EX 19 (31.7%) 14 (35.9%) 
Amount of smoking (pack-year) 24.9 ± 20.3 22.1 ± 18.6 
FEV1/FVC (%) 65.8 ± 12.9 68.7 ± 10.1 
Without AFO 23 (38.3%) 14 (35.9%) 
With AFO 37 (61.7%) 25 (64.1%) 
FEV1 (L) 2.01 ± 0.56 2.63 ± 0.49 
FEV1 (% pred) 87.0 ± 17.9 88.3 ± 15.4 
Mild (>80%) 41 (68.3%) 28 (71.8%) 
Moderate (50 – 80%) 19 (31.7%) 11 (28.2%) 
FVC (L) 3.21 ± 0.73 3.44 ± 0.66 
FVC (% pred) 102.5 ± 15.2 99.8 ± 13.3 
Histology   No abnormality detected 56 (93.3%) 35 (89.8%) 
Moderate squamous 2 (3.4%) 2 (5.1%) 
Squamous metaplasia 2 (3.4%) 2 (5.1%) 
NS = non-smoker, CS = chronic smoker, EX = ex-smoker; 
FEV1 = forced expiratory volume in one second, FVC = forced vital capacity; AFO = 
airflow obstruction; L = liter; % pred = percentage of predicted values 
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Table 2 
 CHRNA3 CHRNA4 CHRNA5 CHRNA6 CHRNA7 CHRNB2 CHRNB3 CHRNB4 
FEV1 0.019 
(p=0.587) 
0.325* 
(p=0.014*) 
0.338* 
(p=0.010*) 
-0.002 
(p=0.059) 
0.370* 
(p=0.004*) 
-0.061 
(p=0.302) 
-0.108 
(p=0.833) 
-0.053 
(p=0.263) 
FEV1 
(% pred) 
0.040 
(p=0.355) 
0.375* 
(p=0.043*) 
0.403* 
(p=0.011*) 
-0.071 
(p=0.071) 
0.425* 
(p=0.023*) 
-0.080 
(p=0.456) 
-0.181 
(p=0.111) 
-0.126 
(p=0.112) 
FVC 0.038 
(p=0.217) 
0.485* 
(p=0.041*) 
0.469* 
(p=0.032*) 
-0.144 
(p=0.231) 
0.471 
(p=0.054) 
-0.179 
(p=0.125) 
-0.050 
(p=0.542) 
-0.061 
(p=0.255) 
FVC 
(% pred) 
0.086 
(p=0.116) 
0.593* 
(p=0.021*) 
0.587* 
(p=0.011*) 
-0.033 
(p=0.067) 
0.576* 
(p=0.013*)       
-0.211 
(p=0.433) 
-0.119 
(p=0.113) 
-0.234 
(p=0.132) 
FEV1/FVC 0.154 
(p=0.213) 
0.037 
(p=0.313) 
0.056 
(p=0.543) 
-0.120 
(p=0.121) 
0.076 
(p=0.073) 
-0.419* 
(p=0.043*) 
-0.079 
(p=0.217) 
-0.072 
(p=0.562) 
 
FEV1 = forced expiratory volume in one second, FVC = forced vital capacity; r values 
are shown correlating lung function parameters with quantitative expression of various 
nAChRs.  Significant p values (* p < 0.05) are underlined in bold. 
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Table 3 
 
Staining by cellular location: bm = surface epithelial cell membrane; bc = surface 
epithelial cytosol; dm = bronchial gland duct membrane; dc = bronchial gland duct 
cytosol; sm = bronchial gland serous cell membrane; sc = bronchial gland serous cell 
cytosol; mm = bronchial gland mucous cell membrane; mc = bronchial gland mucous cell 
cytosol; FEV1 = forced expiratory volume in one second, FVC = forced vital capacity; r 
values are shown with significant values (* p < 0.05) indicated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4 
    Immunohistochemical Expression 
 bm bc dm dc sm sc mm mc 
nAChR α4         
FVC 
(% Pred) -0.439 0.552* 0.019 -0.025 0.363 0.180 0.363 0.123 
nAChR α5         
FEV1 
(% Pred) 0.121 0.066 0.073 -0.295 0.077 0.369* 0.014 0.244 
  nAChR β3         
FEV1 0.177 0.210 -0.088 -0.270 -0.148 0.317 -0.081 0.367* 
 27 
mRNA 
expression 
CHRNA3 CHRNA4 CHRNA5 CHRNA6 CHRNA7 CHRNB2 CHRNB3 
α3 0.067 0.161 0.183 0.086 0.132 0.150 0.292 
α4 0.254 0.579* 0.359* 0.141 0.401* 0.175 0.126 
α5 0.063 0.373* 0.595* 0.079 0.433* 0.149 0.234 
α6 0.139 0.500* 0.360* 0.090 0.252 0.197 0.293 
α7 0.083 0.366* 0.194 0.082 0.552* 0.152 0.227 
β2 0.067 0.139 0.138 0.029 0.031 0.531* 0.253 
β3 0.093 0.128 0.051 0.003 0.118 0.277 0.076 
 
The header row lists the mRNA expression of different nAChR subunit correlating with 
the corresponding nAChR subunit detection by immunohistochemistry in each column. 
Significant correlations are in bold (*p < 0.05). 
 
 
 
 
 
 
 
 
 
